Intestinal epithelial vitamin D receptor signaling inhibits experimental coliti

Journal of Clinical Investigation

Volumn 123, Issue 9, 2013, Pages 3983-3996

  Liu, Weicheng ^a   Chen, Yunzi ^a,b   Golan, Maya Aharoni ^a   Annunziata, Maria L ^a   Du, Jie ^b   Dougherty, Urszula ^a   Kong, Juan ^a,b   Musch, Mark ^a   Huang, Yong ^a   Pekow, Joel ^a   Zheng, Changqing ^b   Bissonnette, Marc ^a   Hanauer, Stephen B ^a   Li, Yan Chun ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CD45RB ANTIGEN; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PUMA PROTEIN; TRINITROBENZENESULFONIC ACID; VITAMIN D RECEPTOR; APOPTOSIS REGULATORY PROTEIN; CALCITRIOL RECEPTOR; PUMA PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DEATH; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; SIGNAL TRANSDUCTION; TRANSGENE; ULCERATIVE COLITIS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLON; EPITHELIUM CELL; GENETICS; HCT116 CELL LINE; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; TIGHT JUNCTION; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; COLITIS; COLON; DEXTRAN SULFATE; EPITHELIAL CELLS; HCT116 CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; TRANSCRIPTIONAL ACTIVATION; TRINITROBENZENESULFONIC ACID; TUMOR SUPPRESSOR PROTEINS;

EID: 84883503073     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI65842     Document Type: Article

References (79)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347(6):417-429. (Pubitemid 34851835)
2. Gibson PR. Increased gut permeability in Crohn's disease: is TNF the link? Gut. 2004;53(12):1724-1725. (Pubitemid 39556884)
3. Laukoetter MG, Bruewer M, Nusrat A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr Opin Gastroenterol. 2006;22(2):85-89. (Pubitemid 44090070)
4. Watson AJ, et al. Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology. 2005;129(3):902-912. (Pubitemid 41242683)
5. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2(9):416-422. (Pubitemid 41486094)
6. Di Sabatino A, et al. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum. 2003;46(11):1498-1507. (Pubitemid 37429731)
7. Hagiwara C, Tanaka M, Kudo H. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J Gastroenterol Hepatol. 2002;17(7):758-764. (Pubitemid 34779736)
8. Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 1996;180(2):152-159. (Pubitemid 26370180)
9. Frey MR, Edelblum KL, Mullane MT, Liang D, Polk DB. The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF. Gastroenterology. 2009;136(1):217-226.
10. Nenci A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446(7135):557-561. (Pubitemid 46514732)
11. Edelblum KL, Yan F, Yamaoka T, Polk DB. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis. 2006;12(5):413-424.
12. Qiu W, et al. PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J Clin Invest. 2011;121(5):1722-1732.
13. Yu J, Zhang L. PUMA, a potent killer with or without p53. Oncogene. 2009;27(suppl 1):S71-S83.
14. Wang P, et al. PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis. Cell Death Differ. 2009;16(9):1192-1202.
15. Bouillon R, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726-776.
16. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
17. Liu N, et al. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology. 2008;149(10):4799-4808.
18. Mukherji A, Kobiita A, Ye T, Chambon P. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell. 2013;153(4):812-827.
19. Haussler MR, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13(3):325-349. (Pubitemid 28146215)
20. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31(1):1-20. (Pubitemid 34733030)
21. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-1517.
22. Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2(7):308-315. (Pubitemid 41102862)
23. Bischoff SC, Herrmann A, Goke M, Manns MP, von zur Muhlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol. 1997;92(7):1157-1163. (Pubitemid 27304813)
24. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37(2):192-199. (Pubitemid 34102257)
25. Marx G, Seidman EG. Inflammatory bowel disease in pediatric patients. Curr Opin Gastroenterol. 1999;15(4):322-325. (Pubitemid 29377251)
26. Pappa HM, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 2006;118(5):1950-1961. (Pubitemid 46393676)
27. Scharla SH, et al. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol. 1994;102(1):44-49.
28. Schulte CM. Review article: bone disease in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(suppl 4):43-49. (Pubitemid 39319246)
29. Sinnott BP, Licata AA. Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review. Endocr Pract. 2006;12(6):622-629.
30. Souza HN, Lora FL, Kulak CA, Manas NC, Amarante HM, Borba VZ. [Low levels of 25-hydroxyvitamin D (25OHD) in patients with inflammatory bowel disease and its correlation with bone mineral density]. Arq Bras Endocrinol Metabol. 2008;52(4):684-691.
31. Vogelsang H, et al. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci. 1989;34(7):1094-1099. (Pubitemid 19188893)
32. Driscoll RH Jr, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology. 1982;83(6):1252-1258. (Pubitemid 13235925)
33. Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut. 1985;26(11):1197-1203. (Pubitemid 16216265)
34. Ulitsky A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011;35(3):308-316.
35. Ananthakrishnan AN, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012;142(3):482-489.
36. Jostins L, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119-124.
37. Naderi N, et al. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2008;23(12):1816-1822.
38. Pei FH, et al. Vitamin D receptor gene polymorphism and ulcerative colitis susceptibility in Han Chinese. J Dig Dis. 2011;12(2):90-98.
39. Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut. 2000;47(2):211-214. (Pubitemid 30489764)
40. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000;130(11):2648-2652.
41. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003;17(12):2386-2392. (Pubitemid 37542204)
42. Kong J, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008;294(1):G208-G216.
43. Pekow J, et al. Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions. Inflamm Bowel Dis. 2013;19(3):461-470.
44. Madison BB, Dunbar L, Qiao XT, Braunstein K, Braunstein E, Gumucio DL. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem. 2002;277(36):33275-33283. (Pubitemid 34984848)
45. Wang Y, et al. Vitamin D receptor signaling in podocytes protects against diabetic nephropathy. J Am Soc Nephrol. 2012;23(12):1977-1986.
46. te Velde AA, Verstege MI, Hommes DW. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis. 2006;12(10):995-999. (Pubitemid 44498288)
47. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2(3):541-546. (Pubitemid 47040018)
48. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98(3):694-702. (Pubitemid 20069706)
49. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69(2):238-249.
50. Ostanin DV, et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol. 2009;296(2):G135-G146.
51. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity. 1995;3(2):171-174.
52. Chen Y, et al. 1,25-Dihydroxyvitamin D(3) suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-kappaB activation. Arch Biochem Biophys. 2011;507(2):241-247.
53. Chen Y, et al. 1,25-Dihydroxyvitamin D promotes negative feedback regulation of Toll-like receptor signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol. 2013;190(7):3687-3695.
54. Sun J, et al. Increased NF-{kappa}B activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab. 2006;291(2):E315-E322. (Pubitemid 44035291)
55. Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. J Biol Chem. 2013;288(27):19450-19458.
56. Abreu MT, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut. 2004;53(8):1129-1136. (Pubitemid 38961967)
57. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med. 1995;182(5):1281-1290.
58. Chen Y, et al. 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol. 2013;190(7):3687-3695.
59. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8(9):685-698.
60. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol. 2011;11(9):584-596.
61. Zasloff M. Antimicrobial peptides in health and disease. N Engl J Med. 2002;347(15):1199-1200.
62. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005;19(9):1067-1077. (Pubitemid 40946432)
63. Wang TT, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285(4):2227-2231.
64. Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A. Crohn's disease: NOD2, autophagy and ER stress converge. Gut. 2011;60(11):1580-1588.
65. Stappenbeck TS, et al. Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy. 2011;7(4):355-374.
66. Yuk JM, et al. Vitamin D3 induces autophagy in human monocytes/ macrophages via cathelicidin. Cell Host Microbe. 2009;6(3):231-243.
67. Cooney RM, Warren BF, Altman DG, Abreu MT, Travis SP. Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation. Trials. 2007;8:17.
68. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut. 1989;30(7):983-989.
69. Li YC, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A. 1997;94(18):9831-9835.
70. Butzner JD, Parmar R, Bell CJ, Dalal V. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut. 1996;38(4):568-573. (Pubitemid 26111377)
71. Beck PL, et al. Exploring the interplay of barrier function and leukocyte recruitment in intestinal inflammation by targeting fucosyltransferase VII and trefoil factor 3. Am J Physiol Gastrointest Liver Physiol. 2010;299(1):G43-G53.
72. Appleyard CB, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol. 1995;269(1 pt 1):G119-G125.
73. Park CM, Reid PE, Walker DC, MacPherson BR. A simple, practical "swiss roll" method of preparing tissues for paraffin or methacrylate embedding. J Microsc. 1987;145(pt 1):115-120. (Pubitemid 17025003)
74. Hyland NP, Chambers AP, Keenan CM, Pittman QJ, Sharkey KA. Differential adipokine response in genetically predisposed lean and obese rats during inflammation: a role in modulating experimental colitis? Am J Physiol Gastrointest Liver Physiol. 2009;297(5):G869-G877.
75. Denning TL, et al. Expression of IL-10 receptors on epithelial cells from the murine small and large intestine. Int Immunol. 2000;12(2):133-139. (Pubitemid 30088305)
76. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A. 2008;105(41):15896-15901.
77. Li YC, Bolt MJG, Cao L-P, Sitrin MD. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. Am J Physiol Endocrinol Metab. 2001;281(3):E558-E564.
78. Mercurio F, et al. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science. 1997;278(5339):860-866. (Pubitemid 27467923)
79. Yuan W, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007;282(41):29821-29830. (Pubitemid 350035242)